Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Ppublish 27 citations
Electronic publication date
June 6, 2014

View on Pubmed.gov 24508733 | View on doi.org 10.1152/ajplung...

Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.

Search for publications in this journal Am J Physiol Lung Cell Mol Physiol - 306(8):L764-74

Abstract

Extracellular proteases including matrix metalloproteinases (MMPs) are speculated to play a significant role in chronic lung diseases, such as asthma. Although increased protease expression has been correlated with lung pathogenesis, the relationship between localized enzyme activity and disease progression remains poorly understood. We report the application of MMP-2/9 activatable cell-penetrating peptides (ACPPs) and their ratiometric analogs (RACPPs) for in vivo measurement of protease activity and distribution in the lungs of mice that were challenged with the allergen ovalbumin. MMP-2/9 activity was increased greater than twofold in whole, dissected lungs from acutely challenged mice compared with control mice (P=1.8×10(-4)). This upregulation of MMP-2/9 activity was localized around inflamed airways with 1.6-fold higher protease-dependent ACPP uptake surrounding diseased airways compared with adjacent, pathologically normal lung parenchyma (P=0.03). MMP-2/9 activity detected by ACPP cleavage colocalized with gelatinase activity measured with in situ dye-quenched gelatin. For comparison, neutrophil elastase activity and thrombin activity, detected with elastase- and thrombin-cleavable RACPPs, respectively, were not significantly elevated in acutely allergen-challenged mouse lungs. The results demonstrate that ACPPs, like the MMP-2/9-activated and related ACPPs, allow for real-time detection of protease activity in a murine asthma model, which should improve our understanding of protease activation in asthma disease progression and help elucidate new therapy targets or act as a mechanism for therapeutic drug delivery.

References

J Allergy Clin Immunol. 1999 Nov;104(5):983-9

Cancer Res. 2013 Jan 15;73(2):855-64

Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1157-61

Int Arch Allergy Immunol. 2000 Nov;123(3):259-67

Cited by 27 citations (total)

Journal Article

ORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathway.

Electronic publication date January 20, 2018

Search for publications in this journal Mol Med Rep

Fei Yu [...] Yulin Wang et al.

ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) has been previously implicated in asthma pathogenesis, its effect on airway remodeling remains to be...

Journal Article Research Support, Non-U.S. Gov't

The role of miR-29c/B7-H3 axis in children with allergic asthma.

Electronic publication date June 21, 2019

Search for publications in this journal J Transl Med

Xinxing Zhang [...] Zhengrong Chen et al.

BACKGROUND

MicroRNAs play roles in the pathogenesis of bronchial asthma. However, the mechanism of miR-29c in allergic asthma remains unclear. This...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances